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tion such as hypertrophy, fibrotic transformation and gene 
expression deficits could be delineated. Taken together, the 
structural and functional findings on alterations of the ENS 
and the enteric musculature in diverticular disease provide 
evidence to strengthen the hypothesis that an enteric neu-
ro-/myopathy may contribute to the development of colon-
ic diverticula and the generation of symptoms in the course 
of the disease.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Diverticular disease is the most common morpholog-
ical abnormality of the colon defined by multiple hernia-
tions of the mucosal and submucosal layers through the 
colonic wall (pseudodiverticula). Due to its high preva-
lence especially in the elderly and the associated compli-
cations, diverticular disease represents the 5th most im-
portant gastrointestinal disease in western countries in 
terms of direct and indirect costs with a mortality rate of 
2.5 per 100,000 population per year  [1] .
 In spite of the worldwide distribution of diverticular 
disease and its socioeconomic impact, the pathogenesis is 
not yet fully clarified and the etiology is considered to be 
multifactorial. Factors which have been shown to favor 
the formation of colonic diverticula include increasing 
age, low fiber diet, and structural as well as functional 
alterations of the colonic wall.
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 Abstract 
 The pathogenesis of diverticular disease is still poorly under-
stood and considered to be multifactorial. Whereas classical 
pathogenetic concepts have focused on risk factors includ-
ing increasing age, low-fiber diet and connective tissue dis-
orders, novel concepts take into account that patients with 
diverticular disease exhibit disturbed intestinal motility pat-
terns (that may result in functional obstruction and painful 
sensations) therefore postulating an underlying enteric neu-
ro-/myopathy. Recent studies including quantitative evalua-
tions of the enteric nervous system (ENS) in diverticular dis-
ease yielded hypoganglionic conditions of both myenteric 
and submucosal plexus as well as a nerve tissue remodeling 
in chronic diverticular disease. The disturbed neuromuscular 
communication was proven by demonstrating alterations in 
several enteric neurotransmitter systems, exemplified for 
the cholinergic, serotonergic, nitrergic system as well as for 
vasointestinal peptide, galanin and tachykinins. Novel lines 
of evidence have added the involvement of neurotrophic 
factors such as glial cell line-derived neurotrophic factor 
which is supposed to regulate ENS development and main-
tenance and which is downregulated in patients with diver-
ticular disease. Consistent with the hypothesis of an enteric 
myopathy, deficits in smooth muscle integrity and composi-
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 Established Etiological Factors 
 Increasing Age 
 One well-established factor triggering the develop-
ment of diverticula is increasing age  [2–4] . Whereas this 
condition is uncommon under the age of 40, the preva-
lence increases rapidly from approximately 20% at the age 
of 50 to around 60% at the age of 70. Although advancing 
age is obviously associated with diverticular disease, this 
association may be ostensible, as it is not the age per se 
but the prolonged time course during which the colonic 
wall is exposed and therefore more susceptible to other 
pathogenetic factors. 
 Low Fiber Intake 
 The major traditional hypothesis concerning the pro-
pensity to form diverticula addresses the consumption of 
dietary fiber  [4–6] . Data from both clinical studies and 
experimental animal models have shown that a low fiber 
intake positively correlates with the formation of diver-
ticula  [7, 8] . As colonic transit time is delayed by a lack of 
dietary fibers  [9] , it has been proposed that a reduction in 
fiber-induced water absorption leads to smaller amounts 
of stool and a diminishment in luminal diameter. Ac-
cording to the law of Laplace, a smaller radius will result 
in higher intraluminal pressure and, hence, facilitate the 
development of diverticula  [4] . However, although di-
etary fibers have been proven to be protective against 
these alterations, there is no clear evidence for a benefit 
of a high fiber intake in asymptomatic diverticular dis-
ease to prevent the onset of symptoms  [8] . 
 Alterations in Connective Tissue 
 Like many other organs, with increasing age the intes-
tine is subject to altered metabolism of extracellular ma-
trix components. The corresponding studies have fo-
cused on structural alterations of the connective tissue. 
Two major extracellular matrix components, collagen 
and elastin, have been found to be altered in diverticular 
disease: smaller, more densely packed collagen fibrils and 
an excessive cross-linking of collagen molecules with in-
creased rigidity and a subsequent loss of tensile strength 
 [10, 11] and an increase of elastic fibers (elastosis) con-
fined to the longitudinal muscle layer with a subsequent 
thickening of the colonic wall  [12] . The higher rigidity of 
the colon is due to reduced reset force more susceptible to 
the formation of diverticula. In addition, more recent 
data have shown that matrix metalloproteinases or their 
inhibitors responsible for collagen metabolism are altered 
in patients with diverticular disease  [13, 14] .
 Novel Pathogenetic Concepts 
 Alterations of Intestinal Motility in Diverticular Disease 
 The most accepted pathophysiologic common final 
pathway resulting in mucosal herniation appears to be
an increased intraluminal pressure. It is thought that
excessive segmental contractions transform the colon-
ic wall into concertina- or bladder-like compartments 
(‘bladder colon’) causing both a functional obstruction 
and painful sensations. Evidence for disturbed motility 
patterns is mainly derived from manometric and myo-
electric studies showing that patients with diverticular 
disease, particularly those with a symptomatic course, 
are characterized by higher intracolonic pressure and in-
creased motility indices after administration of meals or 
provocative pharmacologic agents such as morphine or 
prostigmine  [15–17] . As most of the early investigations 
were biased by inconsistent methodological approaches 
(e.g. patient selection, anatomical site of recording, time 
period of recording), other studies have focused on those 
colonic segments truly affected by diverticula  [18, 19] and 
have prolonged the recording time  [20] revealing that di-
verticular disease is associated with an increased motor 
activity and high-amplitude propagated contractions.
 Enteric Neuromuscular Pathology: An Underlying 
Mechanism for Diverticular Disease? 
 Intact intestinal peristalsis requires the precise inter-
action of all key-components regulating intestinal motil-
ity, namely the enteric nervous system (‘initiators’), en-
teric neurotransmitters and their receptors (‘mediators’), 
and the enteric musculature (‘effectors’). Consequently, 
defects in one or several of these components would re-
sult in altered colonic motility and thus could account for 
the development of diverticula.
 Recently, the ‘London classification of gastrointestinal 
neuromuscular pathology’ defined an enteric neuropathy 
as a histopathology of the enteric nervous system (ENS) 
associated with motility disorders of the gastrointestinal 
tract  [21] . According to these guidelines, colonic motility 
disorders such as congenital and acquired megacolon, 
slow-transit constipation, and chronic intestinal pseudo-
obstruction could be linked to defined enteric neuropa-
thies raising the question whether diverticular disease 
may also fulfil these criteria.
 Alterations of the Initiators of Intestinal Motility: 
Enteric Neuropathy in Diverticular Disease 
 Dating back to 1965, Macbeth and Hawthorn  [22] first 
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characterized by ectopic and enlarged myenteric ganglia 
due to an increase in glial cells. However, it took two
decades until this attractive pathogenetic concept was 
picked up again and re-evaluated by quantifying studies 
of the ENS. 
 Whereas Vuong et al.  [23] could not find relevant al-
terations of the ENS, other studies in patients with diver-
ticular disease were able to confirm a significant decrease 
in enteric nerve cell density  [24, 25] , glial cell tissue  [26] , 
and intramuscular nerve fiber density  [27] . Stoss and 
Meier-Ruge  [28] have primarily focused on the submu-
cosal plexus and described hypertrophied nerve fiber 
strands and so-called submucosal giant ganglia, both fea-
tures resembling what has been defined by Meier-Ruge as 
intestinal neuronal dysplasia  [29] . 
 We recently evaluated morphological changes of the 
ENS according to the guidelines of the London classifica-
tion using HuC/D as a pan-neuronal marker. This anti-
gen is restricted to neuronal somata enabling cell-by-cell 
counts unaffected by co-staining of neuronal processes. 
The systematic quantitation of enteric nerve and glial 
cells revealed a reduced neuronal density in all enteric 
nerve plexus and a decrease of ganglionic nerve cell con-
tent in the myenteric plexus corresponding to an oligo-
neuronal hypoganglionosis  [30] . In addition, the loss of 
enteric neurons was accompanied by decreased myenter-
ic glial cell density.
 Alterations of the Effectors of Intestinal Motility: 
Enteric Myopathy in Diverticular Disease 
 Patients with diverticular disease often show a pecu-
liar thickening of the tunica muscularis affecting both 
the circular and longitudinal muscle layers  [31] . This 
finding does not appear to result from hyperplasia of the 
muscle but instead was rather ascribed to architecturally 
altered myocytes  [32] . In addition, augmented presence 
of elastin has been described  [12] . These changes affect 
mainly the longitudinal muscle layer, whereas the circu-
lar muscle shows normal elastin contents. The subse-
quent shortening of the bowel tube leads to a concertina-
like folding and an excess of mucosal tissue susceptible to 
be pushed through loci minoris resistantiae of the colon-
ic wall. Based on the pathophysiological concept raised 
by Painter and Burkitt  [4] , the longitudinal contraction of 
the bowel wall results in hypersegmentation and the for-
mation of a bladder-colon. Within these compartments 
intraluminal pressures of up to 90 mm Hg may develop 
giving rise to pulsatile pseudodiverticula. 
 By evaluating Azan-stained sections of the colonic 
wall we observed massive intramuscular fibrosis in a sub-
set of patients with diverticular disease. The fibrotic 
transformation affected both muscle layers arguing for a 
degenerative process of the enteric musculature in diver-
ticular disease [Wedel et al., unpubl. observations]. More 
recently, we investigated mRNA expression profiles of 
several components of the contractile apparatus of 
smooth muscle cells by real-time PCR experiments of the 
tunica muscularis obtained from patients with diverticu-
lar disease. mRNA expression of tropomyosin and cal-
desmon was specifically downregulated in patients with 
diverticular disease compared to controls [Böttner et al., 
unpubl. obs.], indicating that the enteric musculature is 
not only compromised at morphological level but also af-
fected by reduced gene expression of proteins essential for 
the functional integrity.
 Alterations of the Mediators of Intestinal Motility: 
Disturbed Neurotransmitter Systems in Diverticular 
Disease 
 The potentially disturbed enteric neuromuscular 
communication has been proven by demonstrating alter-
ations in several enteric neurotransmitter systems: Mil-
ner et al.  [33] have found an increased level of the neu-
rotransmitter vasoactive intestinal polypeptide in pa-
tients with diverticular disease, Golder et al.  [34] described 
lower nitric oxide immunoreactivity in the longitudinal 
muscle, and Simpson et al.  [35] demonstrated significant-
ly higher levels of substance P, neuropeptide K, PACAP, 
galanin and VIP within the mucosal plexus. However, 
these nonuniform and partly contradictory findings in-
dicate that there is no clear evidence that changes in one 
single neurotransmitter might account for the disturbed 
intestinal motility patterns observed in patients with di-
verticular disease. 
 Thus, an alternative approach to study disturbances 
in enteric neurotransmitter systems turned out to aim at 
focusing at the receiving end of neurotransmitters, 
namely to address changes in the corresponding recep-
tors. Along this line, Golder et al.  [27] have investigated 
the role of smooth muscle and neural cholinergic activ-
ity in diverticular disease. The authors described upreg-
ulation of smooth muscle muscarinergic M3 receptors 
concomitantly with an increased sensitivity to exoge-
nous acetylcholine. Recent data from our laboratory 
demonstrate that within the serotonergic system the se-
rotonin 4 receptor is specifically downregulated in the 
tunica muscularis of patients with diverticular disease 
[Böttner et al., unpubl. obs.]. Since this receptor exerts 
excitatory functions within the ENS  [36] and mediates 























   
   
   
   
   
   
   
























help to explain the disturbed intestinal motor patterns 
frequently observed in patients with diverticular dis-
ease.
 Alterations of Neurotrophic Factors: Role of Glial Cell 
Line-Derived Neurotrophic Factor in Diverticular 
Disease 
 Glial cell line-derived neurotrophic factor (GDNF) is 
a crucial signaling molecule regulating the development 
and survival of enteric neurons. Its name is based on the 
fact that the molecule was initially isolated from the su-
pernatant of a glial cell line and characterized by its abil-
ity to promote the survival of cultured dopaminergic 
neurons  [38] . GDNF is a member of the transforming 
growth factor superfamily of growth factors which exert 
various functions in the regulation of the development 
and function of the nervous system  [39] . The GDNF-
induced signal transduction is mediated by a glycosyl-
phosphatidylinositol-coupled GDNF-family receptor-  1 
(GFR-  1) and the tyrosin kinase receptor RET  [40] . Loss 
of GDNF leads to total aganglionosis in the small intes-
tine and colon of mutant mice  [40, 41] . A similar gross 
phenotype is displayed by knock-out mutants in which 
the genes for GFR   1 or RET have been deleted  [42, 43] . 
Furthermore, RET mutations account for 50% of familial 
forms of Hirschsprung’s disease  [44] . 
 Although in diverticular disease the colonic wall does 
not display aganglionosis (complete loss of enteric nerve 
cells), we recently demonstrated that the ENS is charac-
terized by hypoganglionosis (partial loss of enteric nerve 
cells)  [30] and thus addressed the question whether the 
GDNF system may be compromised in diverticular dis-
ease. By means of a low-density PCR array, we found that 
indeed GDNF mRNA expression was downregulated in 
the tunica muscularis of patients with diverticular dis-
ease compared to controls [Böttner et al., unpubl. obs.]. 
Furthermore, in vitro experiments have shown that 
GDNF acts as a neurotrophic factor promoting the sur-
vival and differentiation of cultured postnatal myenteric 
neurons. Taking these findings together, we hypothesize 
that the observed loss of enteric nerve cells in diverticular 
disease may be attributed at least in part to a deficit of 
GDNF and to a subsequent shortfall of its neurotrophic 
potential on enteric neurons.
 Role of Postinflammatory Alterations of the ENS in 
Diverticular Disease 
 Depending upon the degree and duration of inflam-
mation, the mucosa and adjacent tissue layers frequent-
ly display persistent histological alterations following an 
acute phase of diverticulitis. As summarized by Brian 
West et al.  [45] increased lymphoplasmacytic infiltrates 
are observed in the lamina propria associated with mucin 
depletion, cryptitis, architectural distortion, Paneth cell 
metaplasia, and the formation of lymphoglandular com-
plexes. As the ENS extends throughout all the intestinal 
layers, it is conceivable that both enteric nerve fibers and 
ganglia are affected by postinflammatory alterations in 
particular in chronic stages of diverticular disease. In fact, 
Simpson et al.  [35] have described an increase of nerve fi-
bers in the mucosa as well as in the tunica muscularis of 
patients with diverticular disease accompanied by upreg-
ulation of pain-mediating peptides, e.g. substance P, neu-
ropeptide K and galanin. It has been suggested that this 
proliferative nerve remodeling could be considered as
a form of regenerative hyperinnervation leading to in-
creased visceral hypersensitivity and thus the generation 
of persistent symptoms in diverticular disease.
 Conclusions 
 The remaining question that cannot be answered at 
this point is whether the neuromuscular alterations ob-
served in diverticular disease correspond to a primary or 
secondary event – are they hen or egg? If the enteric neu-
romuscular pathology reflects a primary lesion, this 
could in turn lead to disturbed intestinal motility pat-
tern, increased intraluminal pressure and ultimately to 
the formation of diverticula. If inflammatory events are 
considered as the driving force for the neuromuscular ab-
normalities, these changes would arise as secondary le-
sions resembling an associated pathology. 
 It seems conceivable that both concepts may hold true 
in diverticular disease, as on the one hand myenteric 
nerve cell loss has also been reported in patients with 
‘cold diverticula’ speaking in favor of a primary enteric 
neuropathy  [24] , and on the other hand the development 
of postinflammatory alterations of the ENS have been 
proven also in other conditions such as in postinfectious 
irritable bowel syndrome. Therefore, the impact of the 
aforementioned spectrum of enteric neuromuscular pa-
thologies should deserve further attention in regards to 
both the pathogenesis of and the generation of symptoms 
in diverticular disease.
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